Abstract
Glioma has been identified as one of the most aggressive primary tumors. Long non-coding RNAs (lncRNAs), with length larger than 200 bp, have drawn increasing attention to their abnormal expression and regulation function in carcinogenesis. However, the role of lncRNAs in glioma remains largely unknown. Maternally expressed gene 3 (MEG3), also known as gene-trap locus 2 (GTL2), is an imprinted gene, and is encoded by the MEG3 transcript of the DLK1/MEG3 locus on human chromosome, or Meg3 on mouse chromosome. In this study, we found that lncRNA MEG3 was significantly downregulated in malignant glioma tissues and cell lines. The employment of the loss-of and gain-of functions assays presented that MEG3 suppressed glioma cells proliferation and induced cell-cycle arrest. Furthermore, our findings showed that highly expressed MEG3 could weaken Wnt/β-catenin signaling in glioma. Collectively, our findings revealed that downregulated lncRNA MEG3 could promote glioma cell proliferation through targeting Wnt/β-catenin signaling, which mainly influenced cell cycle.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ortega A, Sarmiento JM, Ly D, Nuno M, Mukherjee D, Black KL et al. Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era. J Clin Neurosci 2016; 24: 105–111.
Omuro A, DeAngelis LM . Glioblastoma and other malignant gliomas: a clinical review. JAMA 2013; 310: 1842–1850.
Huang M, Hou J, Wang Y, Xie M, Wei C, Nie F et al. Long noncoding RNA LINC00673 is activated by SP1 and exerts oncogenic properties by interacting with LSD1 and EZH2 in gastric cancer. Mol Ther 2017; 25: 1014–1026.
Jin Y, Cui Z, Li X, Jin X, Peng J . Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer. Oncotarget 2017; 81: 26090–26099.
Li H, Jiang X, Niu X . Long non-coding RNA reprogramming (ROR) promotes cell proliferation in colorectal cancer via affecting P53. Med Sci Monit 2017; 23: 919–928.
Williamson L, Saponaro M, Boeing S, East P, Mitter R, Kantidakis T et al. UV irradiation induces a non-coding RNA that functionally opposes the protein encoded by the same gene. Cell 2017; 168: 843–855.e13.
Xu J, Zhang R, Zhao J . The novel long noncoding RNA TUSC7 inhibits proliferation by sponging MiR-211 in colorectal cancer. Cell Physiol Biochem 2017; 41: 635–644.
Guo J, Cai H, Ma J, Liu X, Liu Y, Zheng J et al. Long non-coding RNA NEAT1 regulates permeability of the blood-tumor barrier via miR-181d-5p-mediated expression changes in ZO-1, occludin, and claudin-5. Biochim Biophys Acta 2017; 1863: 2240–2254.
Hu GW, Wu L, Kuang W, Chen Y, Zhu XG, Guo H et al. Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway. Gene 2017; 610: 24–31.
Meng M, Zhao X, Kong L, Wang A . Long non-coding RNA ENST00462717 suppresses the proliferation, survival, and migration by inhibiting MDM2/MAPK pathway in glioma. Biochem Biophys Res Commun 2017; 485: 513–521.
Xia S, Ji R, Zhan W . Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/beta-catenin signaling pathway. BMC Neurol 2017; 17: 30.
Benetatos L, Vartholomatos G, Hatzimichael E . MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer 2011; 129: 773–779.
Zhang J, Lin Z, Gao Y, Yao T . Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer. J Exp Clin Cancer Res 2017; 36: 5.
Luo G, Wang M, Wu X, Tao D, Xiao X, Wang L et al. Long non-coding RNA MEG3 inhibits cell proliferation and induces apoptosis in prostate cancer. Cell Physiol Biochem 2015; 37: 2209–2220.
Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P et al. The long noncoding RNA MEG3 contributes to cisplatin resistance of human lung adenocarcinoma. PLoS ONE 2015; 10: e0114586.
Zhang K, Zhang J, Han L, Pu P, Kang C . Wnt/beta-catenin signaling in glioma. J Neuroimmune Pharmacol 2012; 7: 740–749.
Atala A . Re: Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. J Urol 2017; 197 (3 Pt 1): 701.
Liu YW, Xia R, Lu K, Xie M, Yang F, Sun M et al. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-mediated H3K4me2 demethylation. Mol Cancer 2017; 16: 39.
Wang Y, Yang T, Zhang Z, Lu M, Zhao W, Zeng X et al. Long non-coding RNA TUG1 promotes migration and invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells. Cancer Sci 2017; 108: 859–867.
Pei Z, Du X, Song Y, Fan L, Li F, Gao Y et al. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/beta-catenin signaling pathway. Oncotarget 2017; 8: 18145–18153.
Schneider JA, Logan SK . Revisiting the role of Wnt/beta-catenin signaling in prostate cancer. Mol Cell Endocrinol 2017 (e-pub ahead of print).
Zhang K, Guo Y, Wang X, Zhao H, Ji Z, Cheng C et al. WNT/beta-catenin directs self-renewal symmetric cell division of hTERThigh prostate cancer stem cells. Cancer Res 2017; 77: 2534–2547.
Acknowledgements
We thank the laboratory members.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Gong, X., Huang, M. Long non-coding RNA MEG3 promotes the proliferation of glioma cells through targeting Wnt/β-catenin signal pathway. Cancer Gene Ther 24, 381–385 (2017). https://doi.org/10.1038/cgt.2017.32
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2017.32
This article is cited by
-
p53-regulated lncRNAs in cancers: from proliferation and metastasis to therapy
Cancer Gene Therapy (2023)
-
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors
Journal of Neuro-Oncology (2023)
-
An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients
Cellular and Molecular Neurobiology (2021)
-
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Molecular Cancer (2019)
-
STAT3-induced upregulation of lncRNA MEG3 regulates the growth of cardiac hypertrophy through miR-361-5p/HDAC9 axis
Scientific Reports (2019)